Arvaya Healthcare board approves insurance broking subsidiary setup

1 min read     Updated on 12 Aug 2026, 11:53 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Arvaya Healthcare Limited has moved into the insurance broking space by approving a wholly-owned subsidiary. The board meeting on August 12, 2026, finalized the plan to incorporate the entity in India with 100% ownership. The subsidiary requires IRDAI approval to operate, with subscription terms yet to be determined. This expansion diversifies the company's revenue streams beyond its core healthcare business.

powered bylight_fuzz_icon
48104597

*this image is generated using AI for illustrative purposes only.

Arvaya Healthcare board approved the incorporation of a wholly-owned subsidiary to enter the insurance broking sector. The decision was taken at a meeting held on August 12, 2026, marking a strategic expansion into financial services adjacent to its healthcare operations.

The proposed entity will be incorporated in India and will operate as a related party to the listed company. Arvaya Healthcare will retain 100% shareholding in the new venture. The specific name of the subsidiary is pending approval from relevant authorities, and the cost of subscription remains undecided.

Regulatory Approvals Required

The subsidiary must obtain regulatory clearance before commencing operations. The company stated it will apply to the Insurance Regulatory Development Authority of India (IRDAI) for approval to conduct insurance broking business. This regulatory step is mandatory under current Indian insurance laws.

Particulars Details
Business Line Insurance broking service
Ownership 100% by Arvaya Healthcare
Incorporation Country India
Regulatory Approval IRDAI approval required

Disclosure Compliance

The company issued the intimation pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure also references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Kaushal Shah, Managing Director, signed the filing on behalf of the company.

Historical Stock Returns for Arvaya Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.96%-11.04%+25.08%+113.78%+365.63%+408.82%

How might the transition into insurance broking impact Arvaya Healthcare's revenue diversification and profit margins in the medium term?

What is the expected timeline for obtaining IRDAI approval, and what specific regulatory hurdles could delay the subsidiary's operational launch?

Will Arvaya leverage its existing healthcare client base to cross-sell insurance products, and if so, what is the projected customer acquisition cost?

Bijoy Hans Ltd publishes corrigendum to postal ballot notice

0 min read     Updated on 18 Jul 2026, 08:16 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Bijoy Hans Ltd has issued a corrigendum to its Postal Ballot Notice dated July 17, 2026, published in the Financial Express and Dainandin Barta on July 18, 2026. The document is available on the company's website, NSDL, and BSE platforms.

powered bylight_fuzz_icon
45931593

*this image is generated using AI for illustrative purposes only.

bijoy hans has issued a corrigendum to its Postal Ballot Notice dated July 17, 2026. The company published the corrigendum in the Financial Express and Dainandin Barta on July 18, 2026. The document is intended to be read in conjunction with the original Postal Ballot Notice.

The corrigendum has been uploaded on the company's website at https://www.arvayahealth.com . It is also available on the National Securities Depository Limited (NSDL) website and the BSE Limited website. The filing was made under Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The intimation was submitted to the Corporate Relationship Department of BSE Limited. The communication was signed by Kaushal Uttam Shah, Managing Director of the company. The company's scrip code is 524723 and the Scrip ID is ARVAYA.

Historical Stock Returns for Arvaya Healthcare

1 Day5 Days1 Month6 Months1 Year5 Years
-1.96%-11.04%+25.08%+113.78%+365.63%+408.82%

What specific changes or corrections does the corrigendum introduce to the original Postal Ballot Notice?

How might the issuance of the corrigendum impact shareholder voting outcomes or participation?

Could the timing of the corrigendum affect the company's compliance with SEBI regulations or shareholder approval timelines?

More News on Arvaya Healthcare

1 Year Returns:+365.63%